Star Imaging IPO: Final Day Frenzy! Subscription Status, GMP, and All You Need to Know
Star Imaging & Path Lab’s SME IPO, priced at Rs 135–Rs142 per share, has been subscribed 2.57 times on Day 3, with strong QIB participation. The Rs 69.47 crore issue closes on August 12, with allotment on August 13 and listing on BSE SME on August 18. No notable grey market premium yet.
- Republic Business
- 2 min read
The SME initial public offering (IPO) of Star Imaging & Path Lab Ltd. entered its third day of bidding today, drawing steady interest from investors.
Star Imaging IPO: Price band
The public issue, which opened on August 8, is priced in the range of Rs 135 to Rs 142 per share. Through this offering, the company aims to raise a total of Rs 69.47 crore, which includes a fresh issue of shares worth Rs 55.66 crore and an offer-for-sale component of Rs 13.80 crore.
Star Imaging IPO: Grey Market Premium
Star Imaging and Path Lab Limited's SME IPO, which closed on August 12, 2025, had a last reported grey market premium (GMP) of Rs 3 as of 4:55 PM on the same day. With the addition of the GMP, the estimated listing price is Rs 145, indicating an expected listing gain of approximately 2.11%, as per a leading market tracking website.
Advertisement
Star Imaging IPO: Subscription status
Market data shows that by Day 3, the IPO had been subscribed 2.57 times overall. The retail investor segment recorded 1.12 times subscription, indicating measured but steady participation from small investors. According to IPO tracking portals, interest from institutional buyers has been notably stronger, with qualified institutional buyers (QIBs) subscribing 4.21 times their allotted portion. Non-institutional investors (NIIs) subscribed at 1.27 times, while retail investors were close to full subscription at 0.97 times in some market tallies.
Star Imaging IPO: Key dates
The IPO will remain open for bidding until August 12, after which the allotment process is expected to take place on August 13. If all goes according to schedule, the company’s shares are likely to be listed on the BSE SME platform on August 18.
Advertisement
About the company
Star Imaging & Path Lab is a diagnostic testing network providing services in pathology, radiology, cardiology, and neurology. They operate under business-to-consumer (B2C), business-to-business (B2B), and business-to-government (B2G) models. The company offers a wide range of tests, including X-rays, CT scans, MRI scans, ultrasounds, and various pathology tests. Star Imaging & Path Lab also has a tele-radiology hub for centralized reporting.
Disclaimer: The views expressed in this article are purely informational, and Republic Media Network does not vouch for, promote or endorse any opinions stated by any third party. Stock market and Mutual Fund investments are subject to market risks, and readers are advised to seek expert advice before investing in stocks, derivatives and Mutual Funds.